Study of Tecovirimat for Human Mpox Virus
Stopped early · Phase 3 · Has a placebo group
Conditions studied: MPOX
In brief
The purpose of this study was to see if tecovirimat is safe and successful at treating mpox. The main questions were whether tecovirimat reduced time to lesion resolution and pain compared to placebo (no treatment).
Key facts
- Study ID
- NCT05534984
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 719
- Starts
- 2022-09-08
- Expected to finish
- 2025-02-22
- Last updated by the study team
- 2026-06-23
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Kaiser Permanente Los Angeles Medical Center — Los Angeles, California, United States
- Los Angeles LGBT Center CRS — Los Angeles, California, United States
- UCLA CARE Center CRS — Los Angeles, California, United States
- University of California, Davis CRS — Sacramento, California, United States
- UCSD Antiviral Research Center CRS — San Diego, California, United States
- University of California, San Francisco HIV/AIDS CRS — San Francisco, California, United States
- Harbor University of California Los Angeles Center — Torrance, California, United States
- University of Colorado Denver NICHD CRS — Aurora, Colorado, United States
- University of Colorado Hospital CRS — Aurora, Colorado, United States
- Denver Public Health CRS — Denver, Colorado, United States
- University of Florida — Gainesville, Florida, United States
- University of Florida Jacksonville NICHD CRS — Jacksonville, Florida, United States
- University of Miami / Jackson Memorial Hospital — Miami, Florida, United States
- Univ. of South Florida (USF) College of Medicine A — Tampa, Florida, United States
- The Ponce de Leon Center CRS — Atlanta, Georgia, United States
- Rush University Cook County Hospital Chicago NICHD CRS — Chicago, Illinois, United States
- Johns Hopkins University CRS — Baltimore, Maryland, United States
- Massachusetts General Hospital CRS (MGH CRS) — Boston, Massachusetts, United States
- Brigham and Women's Hospital Therapeutics — Boston, Massachusetts, United States
- Henry Ford Hospital CRS — Detroit, Michigan, United States
- Washington University Therapeutics (WT) CRS — St Louis, Missouri, United States
- New Jersey Medical School Clinical Research Center — Newark, New Jersey, United States
- Weill Cornell Chelsea CRS — New York, New York, United States
- Mount Sinai West Samuels CRS — New York, New York, United States
- Alabama CRS — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.